Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia.

S K Schultz1, N C Andreasen

  • 1Mental Health Clinical Research Center, Department of Psychiatry, University of Iowa, Iowa City 52242, USA. susan-schultz@uiowa.edu

Lancet (London, England)
|May 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterogeneity in 10-year course trajectories of moderate to severe major depressive disorder among veterans.

Epidemiology and psychiatric sciences·2024
Same author

Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction.

Molecular psychiatry·2017
Same author

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Neuroscience and biobehavioral reviews·2013
Same author

MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.

Psychological medicine·2012
Same author

Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes.

Molecular psychiatry·2011
Same author

Auditory and visual attention assessed with PET.

Human brain mapping·2010
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Schizophrenia is a severe psychiatric disorder. Research explores genetic and neural factors, but treatments for symptoms and impairments remain challenging.

Area of Science:

  • Psychiatry and Neuroscience

Background:

  • Schizophrenia is a severe psychiatric disorder characterized by positive and negative symptoms.
  • Negative symptoms significantly impact the illness's course and outcomes.
  • Current diagnostic systems rely on symptom criteria.

Purpose of the Study:

  • To investigate the causal mechanisms of schizophrenia.
  • To explore genetic transmission models and neural connectivity.
  • To understand the role of specific brain regions in schizophrenia.

Main Methods:

  • Utilizing polygenic models of inheritance in genetic research.
  • Conducting neuroimaging studies with magnetic resonance imaging (MRI) and positron emission tomography (PET).
  • Examining neural connectivity, function, and regional brain volumes.

Related Experiment Videos

Main Results:

  • Identified potential genes conferring vulnerability, possibly interacting with environmental factors.
  • Observed differences in volumes and functional dysregulation in key brain areas (frontal/temporal cortex, hippocampus, thalamus, cerebellum).
  • Investigated neural connectivity and function.

Conclusions:

  • Despite advances in understanding genetic and neural underpinnings, effective treatments for schizophrenia symptoms and impairments are still limited.
  • Further research into causal mechanisms is crucial for developing better therapeutic strategies.